lobbying_activities: 584067

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
584067	4f89a0eb-cb34-4be8-9e3e-10b543cbb827	Q1	THE DUBERSTEIN GROUP INC.	12675	NORVARTIS CORP	2008	first_quarter	HCR	Follow-on biologics - HR 1038, Access to Life-Saving Medicine Act; HR 1956, Patient Protection and Innovative Biologic Medicines Act of 2007; S 623, Access to Life-Saving Medicine Act; S 1505, Affordable Biologics for Consumers Act; S 1695, Biologics Price Competition and Innovation Act of 2007. Budget, funding for pandemic flu production facilities - Proposed legislation and Exec. Branch actions regarding this matter.	HOUSE OF REPRESENTATIVES,Natl Security Council (NSC),Office of Management & Budget (OMB),Office of the Vice President of the United States,SENATE,White House Office	100000		0	0	2008-03-16T14:52:31-04:00